The latest data point in Q1'27 shows SG&A Expenses at 1.06B USD, while R&D Expenses remain at zero with no data reported. From Q2'24 to Q1'27, SG&A Expenses exhibited an overall upward trend with notable quarterly fluctuations, rising from 817M USD to 1.06B USD, with the most significant spikes occurring in Q4 periods reaching peaks of 1.14B USD in Q4'25 and 1.18B USD in Q4'26, while R&D Expenses maintained zero values throughout the entire period.